Shaban Eman E, Shaban Ahmed E, Shokry Atef, Iftikhar Haris, Zaki Hany A
Cardiology, Aljufairi Diagnostic and Therapeutic Hospital, Doha, QAT.
Internal Medicine, Mansoura General Hospital, Mansoura, EGY.
Cureus. 2022 Jan 9;14(1):e21050. doi: 10.7759/cureus.21050. eCollection 2022 Jan.
Non-ST-elevation myocardial infarction (NSTEMI) has a less severe ratio of acute coronary syndromes compared with ST-segment elevation myocardial infarction (STEMI), arising from complete occlusion of a major coronary artery. The name implies a syndrome that does not exhibit the dramatic ST-elevation seen in the traditional 12-lead ECG in chest pain patients with a confirmed diagnosis of STEMI. The crucial clinical significance of NSTEMI is that delay in diagnosis can lead to increased morbidity, risk of arrhythmia, and death. It was recently reported that atrial fibrillation (AF) correlates with the risk rise of myocardial infarction (MI), although the mechanism underlying this association is currently unknown. Does atrial fibrillation with decompensated heart failure (DHF) get complicated with NSTEMI? In this article, we describe the case of a 77-year-old male patient diagnosed and admitted as NSTEMI complicated by DHF.
非ST段抬高型心肌梗死(NSTEMI)与ST段抬高型心肌梗死(STEMI)相比,在急性冠状动脉综合征中病情较轻,后者由主要冠状动脉完全闭塞引起。这个名称意味着该综合征在确诊为STEMI的胸痛患者的传统12导联心电图中不会出现明显的ST段抬高。NSTEMI的关键临床意义在于诊断延迟会导致发病率增加、心律失常风险和死亡风险增加。最近有报道称,心房颤动(AF)与心肌梗死(MI)风险增加相关,尽管这种关联的潜在机制目前尚不清楚。失代偿性心力衰竭(DHF)合并的心房颤动会并发NSTEMI吗?在本文中,我们描述了一名77岁男性患者的病例,该患者被诊断为并发DHF的NSTEMI并入院治疗。